For women of every age, we treat a full spectrum of gynecologic health issues. So whether you are in your teens or a Baby Boomer and beyond,
- Wellness Exams, including pap smears, breast exams and referral to 3D mammography
- Birth Control Options
- Hysterectomy, including vaginal, laparoscopic/vaginal and robotic-assisted
- Minimally Invasive Surgery, including robotic-assisted surgery
- Menopause and Hormone Replacement Options
- Menstruation issues
- Pelvic Pain and Prolapse
- Urinary Incontinence
BRACAnalysis® Testing for Hereditary Breast and Ovarian Cancer
BRACAnalysis® is a genetic test that confirms the presence of a BRCA1 or BRCA2 gene mutation, responsible for the majority of hereditary breast and ovarian cancers. People who carry the inherited gene mutation have risks of up to 87 percent for developing breast cancer and up to 44 percent for developing ovarian cancer by age 70. Mutation carriers previously diagnosed with cancer also have a significantly increased risk of developing a second primary cancer. The BRACAnalysis test identifies patients who have these mutations.
BRACAnalysis is a simple blood test or oral rinse sample to find out if you have the BRCA1 or BRCA2 mutation. Knowing the results helps you decide with your doctor on a course of action before cancer has a chance to develop.
COLARIS® Testing for Hereditary Colorectal and Uterine Cancer
COLARIS® is a genetic test that assesses a person’s risk of developing hereditary colorectal cancer and a woman’s risk of developing hereditary uterine cancer. COLARISPLUS detects disease-causing mutations in genes that are responsible for the majority of Lynch syndrome and MYH-associated polyposis (MAP) cases.
Lynch syndrome, also known as Hereditary Nonpolyposis Colorectal Cancer (HNPCC), is the most common of the hereditary colon cancer syndromes and is believed to account for 3 percent to 5 percent of all colorectal cancers.
MAP is caused by mutations in the MYH gene. Individuals with MAP have mutations in both of their MYH genes (one from each parent). Patients often have no family history of colon cancer or polyps in parents, although siblings may be affected.
COLARIS is a simple blood test or oral rinse sample to detect disease-causing mutations in the MLH1, MSH2, MSH6, PMS2, EPCAM or MYH genes. Knowing the results may help you and your doctor act before cancer has a chance to develop.